FDA already may be nearing the peak of its ability to approve applications during the first review cycle, less than a year into use of a new review system intended for that purpose.
The agency’s first-cycle approval rate, which measures the portion of submitted applications successfully cleared before their first user fee goal date, is so high now
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?